Meningiomas Associated with Subdural Hematomas: A Systematic Review of Clinical Features and Outcomes

Abdelsimar T Omar1, Yves P Starreveld1

  • 1Division of Neurosurgery, Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

World Neurosurgery
|November 11, 2021
PubMed
Abstract

Insights

Meningiomas rarely cause subdural hematomas (SDHs). Surgical management is key for these rare intracranial tumors, with most patients experiencing complete neurologic recovery after treatment.

Area of Science:

  • Neuro-oncology
  • Neurosurgery
  • Neurology

Background:

  • Meningiomas associated with subdural hematomas (SDHs) are exceptionally rare.
  • Limited understanding exists regarding the clinical presentation, management, and outcomes for these specific cases.

Purpose of the Study:

  • To systematically review and synthesize existing literature on meningiomas presenting with SDH.
  • To elucidate the clinical features, treatment strategies, and patient outcomes.

Main Methods:

  • A systematic review of PubMed and Scopus databases was conducted.
  • Case reports and series of patients with meningioma and SDH were analyzed.
  • Data collected included demographics, clinical symptoms, surgical interventions, and follow-up outcomes.

Main Results:

  • Fifty-nine cases were included, with a mean patient age of 62 years and a slight female predominance.
  • Headache and focal weakness were the most frequent symptoms and signs.
  • Surgery was performed in most patients, with a 12% mortality rate and 71% complete neurologic recovery.

Conclusions:

  • Subdural hematomas are uncommon presentations of intracranial meningiomas.
  • Surgical intervention is the primary management approach for both mass effect relief and tumor control.
  • The majority of patients treated for meningioma-associated SDH achieve complete neurologic recovery.